ArticleClinical and experimental dental research2026
Quercetin Inhibits Orthodontic Tooth Movement-Associated Periodontitis by Regulating Macrophage Aerobic Glycolysis Through the IL-17/Hippo/YAP Axis.
Article in Clinical and experimental dental research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Quercetin Inhibits Orthodontic Tooth Movement-Associated Periodontitis by Regulating Macrophage Aerobic Glycolysis Through the IL-17/Hippo/YAP Axis.Clinical and experimental dental research · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
objectivesOrthodontic tooth movement (OTM) is frequently accompanied by inflammatory responses, including periodontitis, which may compromise treatment outcomes. This study investigated the protective role of quercetin, a natural flavonoid, in OTM-associated periodontitis and its underlying mechanism involving macrophage metabolic reprogramming via the IL-17/Hippo/YAP axis. MATERIAL AND
methodsAn in vivo OTM model was established using YAP-wild-type and YAP-knockout Sprague-Dawley rats to assess the effects of quercetin on periodontal inflammation and alveolar bone resorption. In vitro studies were conducted using the RAW264.7 macrophage cell line treated with quercetin (0.1-10 μM). Key methodologies included micro-CT analysis for alveolar bone loss, histopathological evaluation (H&E and TRAP staining), qPCR and western blot analysis for gene and protein expression, ELISA for cytokine quantification, flow cytometry for apoptosis and cell cycle analysis, and CCK-8 assays for cell viability. The role of YAP was further validated using specific inhibitors and genetic knockout models.
resultsQuercetin administration significantly attenuated periodontal inflammation and alveolar bone loss in the OTM model. In RAW264.7 macrophages, quercetin suppressed IL-17-induced activation of the Hippo/YAP pathway, inhibited YAP nuclear translocation, and downregulated the expression of key glycolytic enzymes (HK2, LDHA, and PKM2). Consequently, quercetin reduced lactate production and aerobic glycolysis. These effects were reversed upon YAP overexpression, confirming the pivotal role of the IL-17/Hippo/YAP axis in quercetin-mediated metabolic modulation.
conclusionsQuercetin alleviates OTM-associated periodontitis by inhibiting the IL-17/Hippo/YAP signaling pathway, thereby suppressing macrophage aerobic glycolysis. These findings highlight quercetin as a potential therapeutic adjunct in orthodontics to mitigate inflammatory complications.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.